C.R. Bard Company Profile (NYSE:BCR)

About C.R. Bard

C.R. Bard logoC. R. Bard, Inc. (Bard) and its subsidiaries are engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company sells its products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities. It operates through the manufacturing and sale of medical devices segment. Its vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease (PVD), end-stage renal disease (ESRD) and heart arrhythmias. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers and other diseases and disorders. Its surgical specialty products include implanted grafts and fixation devices for hernia and soft tissue repairs.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: BCR
  • CUSIP: 06738310
Key Metrics:
  • Previous Close: $228.59
  • 50 Day Moving Average: $221.30
  • 200 Day Moving Average: $218.86
  • 52-Week Range: $172.21 - $239.43
  • Trailing P/E Ratio: 52.74
  • Foreward P/E Ratio: 20.10
  • P/E Growth: 2.06
  • Market Cap: $16.66B
  • Outstanding Shares: 73,454,000
  • Beta: 0.57
Profitability:
  • Net Margins: 9.20%
  • Return on Equity: 48.43%
  • Return on Assets: 14.33%
Debt:
  • Debt-to-Equity Ratio: 1.01%
  • Current Ratio: 2.36%
  • Quick Ratio: 1.85%
Additional Links:
Companies Related to C.R. Bard:

Analyst Ratings

Consensus Ratings for C.R. Bard (NYSE:BCR) (?)
Ratings Breakdown: 12 Hold Ratings, 6 Buy Ratings
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $232.46 (2.27% upside)

Analysts' Ratings History for C.R. Bard (NYSE:BCR)
Show:
DateFirmActionRatingPrice TargetDetails
9/27/2016Jefferies GroupReiterated RatingHold$237.00View Rating Details
9/16/2016Wells Fargo & Co.UpgradeMarket Perform -> OutperformView Rating Details
9/15/2016Evercore ISIInitiated CoverageBuy$235.00View Rating Details
7/28/2016Morgan StanleyReiterated RatingHold$240.00View Rating Details
7/28/2016Leerink SwannReiterated RatingMarket Perform$240.00 -> $233.00View Rating Details
7/27/2016JPMorgan Chase & Co.Boost Price TargetNeutral$214.00 -> $225.00View Rating Details
7/27/2016BMO Capital MarketsReiterated RatingHold$240.00View Rating Details
7/27/2016Citigroup Inc.Boost Price TargetBuy$241.00 -> $265.00View Rating Details
7/27/2016Deutsche Bank AGBoost Price TargetHold$234.00 -> $240.00View Rating Details
7/27/2016Barclays PLCBoost Price TargetEqual Weight$224.00 -> $235.00View Rating Details
7/8/2016Bank of America Corp.DowngradeBuy -> NeutralView Rating Details
5/24/2016Piper Jaffray Cos.Reiterated RatingBuy$241.00View Rating Details
5/24/2016Needham & Company LLCReiterated RatingHoldView Rating Details
3/17/2016NomuraInitiated CoverageNeutral$205.00View Rating Details
1/29/2016Goldman Sachs Group Inc.Lower Price TargetBuy$214.00 -> $211.00View Rating Details
1/27/2016JMP SecuritiesBoost Price TargetMarket Outperform$207.00 -> $215.00View Rating Details
10/23/2015Brean CapitalReiterated RatingHoldView Rating Details
10/23/2015William BlairReiterated RatingHoldView Rating Details
8/27/2015KeyCorpInitiated CoverageSector WeightView Rating Details
(Data available from 9/29/2014 forward)

Earnings

Earnings History for C.R. Bard (NYSE:BCR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/20/2016        
7/26/2016Q2$2.47$2.54$915.22 million$931.50 millionViewListenView Earnings Details
4/27/2016Q116$2.17$2.34$845.77 million$873.50 millionViewListenView Earnings Details
1/28/2016Q415$2.41$2.43$867.22 million$870.80 millionViewListenView Earnings Details
10/22/2015Q3$2.24$2.28$852.93 million$865.70 millionViewListenView Earnings Details
7/23/2015Q2$2.18$2.27$836.18 million$859.80 millionViewListenView Earnings Details
4/23/2015Q115$2.07$2.10$813.36 million$819.70 millionViewListenView Earnings Details
1/29/2015Q414$2.24$2.29$855.11 million$867.20 millionViewListenView Earnings Details
10/22/2014Q314$2.10$2.15$819.20 million$830.00 millionViewListenView Earnings Details
7/24/2014Q214$2.01$2.06$814.58 million$827.10 millionViewListenView Earnings Details
4/22/2014Q114$1.85$1.91$787.10 million$799.30 millionViewListenView Earnings Details
1/30/2014Q413$1.41$1.42$782.28 million$791.30 millionViewListenView Earnings Details
10/22/2013Q313$1.40$1.50$739.12 million$758.00 millionViewListenView Earnings Details
7/23/2013Q2 2013$1.38$1.42$750.91 million$759.90 millionViewListenView Earnings Details
4/23/2013Q1 2013$1.42$1.44$728.45 million$740.30 millionViewListenView Earnings Details
1/31/2013Q4 2012$1.67$1.70$757.49 million$762.60 millionViewListenView Earnings Details
10/23/2012$1.64$1.64ViewN/AView Earnings Details
7/25/2012$1.64$1.62ViewN/AView Earnings Details
1/31/2012$1.68$1.70ViewN/AView Earnings Details
10/25/2011$1.60$1.62ViewN/AView Earnings Details
7/21/2011$1.57$1.57ViewN/AView Earnings Details
4/21/2011$1.46$1.51ViewN/AView Earnings Details
1/31/2011$1.48$1.54ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for C.R. Bard (NYSE:BCR)
Current Year EPS Consensus Estimate: $10.16 EPS
Next Year EPS Consensus Estimate: $11.31 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$2.16$2.38$2.24
Q2 20164$2.45$2.47$2.46
Q3 20164$2.54$2.58$2.55
Q4 20164$2.73$2.75$2.74
Q1 20172$2.54$2.58$2.56
Q2 20172$2.73$2.81$2.77
Q3 20172$2.86$2.94$2.90
Q4 20172$2.97$3.10$3.04
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for C.R. Bard (NYSE:BCR)
Annual Dividend:$1.04
Dividend Yield:0.46%
Dividend Growth:5.70% (3 Year Average)
Payout Ratio:24.24% (Based on Trailing 12 Months of Earnings)
10.24% (Based on Current Year Consensus EPS Estimate)
9.20% (Based on Next Year Consensus EPS Estimate)
Track Record:44 Years of Consecutive Dividend Growth

Dividend History for C.R. Bard (NYSE:BCR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/8/2016quarterly$0.260.46%7/14/20167/18/20167/29/2016
4/20/2016quarterly$0.240.46%4/28/20165/2/20165/13/2016
12/9/2015quarterly$0.240.52%1/21/20161/25/20162/5/2016
10/14/2015quarterly$0.240.5%10/22/201510/26/201511/6/2015
6/10/2015quarterly$0.240.56%7/16/20157/20/20157/31/2015
4/15/2015quarterly$0.220.52%4/23/20154/27/20155/8/2015
12/10/2014quarterly$0.220.52%1/22/20151/26/20152/6/2015
10/8/2014quarterly$0.220.59%10/16/201410/20/201410/31/2014
6/11/2014quarterly$0.220.62%7/17/20147/21/20148/1/2014
4/16/2014quarterly$0.210.6%4/24/20144/28/20145/9/2014
12/11/2013quarterly$0.210.63%1/16/20141/21/20141/31/2014
10/9/2013quarterly$0.210.72%10/17/201310/21/201311/1/2013
6/12/2013quarterly$0.210.77%7/18/20137/22/20138/2/2013
4/17/2013quarterly$0.200.8%4/25/20134/29/20135/10/2013
12/12/2012quarterly$0.200.83%1/17/20131/22/20132/1/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for C.R. Bard (NYSE:BCR)
Insider Ownership Percentage: 0.97%
Institutional Ownership Percentage: 87.90%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/26/2016Timothy M RingChairmanSell110,000$228.96$25,185,600.00View SEC Filing  
9/19/2016Betty D LarsonVPSell4,032$225.33$908,530.56View SEC Filing  
9/6/2016John A. DefordVPSell7,928$221.06$1,752,563.68View SEC Filing  
5/27/2016Christopher S HollandCFOSell3,970$219.89$872,963.30View SEC Filing  
5/17/2016John P GroetelaarsInsiderSell1,162$219.88$255,500.56View SEC Filing  
5/12/2016Tommy G ThompsonDirectorSell500$219.52$109,760.00View SEC Filing  
5/5/2016Tony L WhiteDirectorSell1,200$216.19$259,428.00View SEC Filing  
4/28/2016Jim C BeasleyInsiderSell4,709$215.00$1,012,435.00View SEC Filing  
4/27/2016Sharon M LuboffVPSell10,000$210.00$2,100,000.00View SEC Filing  
3/29/2016Christopher S HollandCFOSell1,650$200.00$330,000.00View SEC Filing  
2/25/2016Jim C BeasleyInsiderSell1,113$195.27$217,335.51View SEC Filing  
2/23/2016Frank Lupisella JrVPSell2,300$190.25$437,575.00View SEC Filing  
2/22/2016Christopher S HollandCFOSell618$190.00$117,420.00View SEC Filing  
2/22/2016Patricia G ChristianVPSell3,182$190.00$604,580.00View SEC Filing  
2/17/2016John A. DefordVPSell661$187.44$123,897.84View SEC Filing  
2/17/2016John H. WeilandCOOSell1,618$187.45$303,294.10View SEC Filing  
2/17/2016Timothy M. RingCEOSell2,453$187.62$460,231.86View SEC Filing  
2/17/2016Timothy P. CollinsinsiderSell974$187.48$182,605.52View SEC Filing  
2/16/2016Anthony WeltersDirectorSell1,784$187.47$334,446.48View SEC Filing  
2/12/2016Christopher S. HollandCFOSell6,297$181.08$1,140,260.76View SEC Filing  
2/12/2016John A. DefordVPSell6,400$182.40$1,167,360.00View SEC Filing  
2/12/2016John H. WeilandCOOSell15,632$182.86$2,858,467.52View SEC Filing  
2/12/2016Timothy M. RingCEOSell24,003$182.76$4,386,788.28View SEC Filing  
2/12/2016Timothy P. CollinsinsiderSell7,893$182.28$1,438,736.04View SEC Filing  
2/10/2016John P. GroetelaarsinsiderSell3,319$187.16$621,184.04View SEC Filing  
2/9/2016John A. DefordVPSell3,407$180.62$615,372.34View SEC Filing  
2/9/2016John H. WeilandCOOSell8,898$181.10$1,611,427.80View SEC Filing  
2/9/2016Timothy M. RingCEOSell4,836$181.20$876,283.20View SEC Filing  
2/9/2016Timothy P. CollinsinsiderSell4,205$181.24$762,114.20View SEC Filing  
2/2/2016Tommy G ThompsonDirectorSell2,319$188.75$437,711.25View SEC Filing  
12/16/2015John H. WeilandCOOSell19,686$188.49$3,710,614.14View SEC Filing  
12/16/2015Patricia G ChristianVPSell1,908$190.00$362,520.00View SEC Filing  
12/14/2015Jim C. BeasleyinsiderSell20,577$184.78$3,802,218.06View SEC Filing  
12/14/2015John A. DefordVPSell5,627$184.00$1,035,368.00View SEC Filing  
12/14/2015John H. WeilandCOOSell33,569$184.25$6,185,088.25View SEC Filing  
11/30/2015Timothy M. RingCEOSell22,052$187.37$4,131,883.24View SEC Filing  
10/29/2015Timothy M. RingCEOSell30,543$184.79$5,644,040.97View SEC Filing  
10/27/2015Gail K. NaughtonDirectorSell2,458$181.99$447,331.42View SEC Filing  
9/29/2015Timothy M. RingCEOSell40,000$185.16$7,406,400.00View SEC Filing  
8/31/2015Timothy M. RingCEOSell40,000$195.17$7,806,800.00View SEC Filing  
8/18/2015Sharon M. LuboffVPSell2,374$199.76$474,230.24View SEC Filing  
8/17/2015Sharon M LuboffVPSell2,030$200.00$406,000.00View SEC Filing  
8/14/2015Tommy G ThompsonDirectorSell1,200$199.25$239,100.00View SEC Filing  
7/13/2015John P GroetelaarsInsiderSell2,456$175.00$429,800.00View SEC Filing  
7/13/2015Timothy M RingCEOSell20,000$176.04$3,520,800.00View SEC Filing  
4/28/2015Tommy G ThompsonDirectorSell1,200$170.43$204,516.00View SEC Filing  
3/23/2015Timothy M RingCEOSell7,628$170.65$1,301,718.20View SEC Filing  
2/23/2015Timothy M RingCEOSell20,000$176.33$3,526,600.00View SEC Filing  
2/19/2015Jim C BeasleyInsiderSell2,884$174.79$504,094.36View SEC Filing  
2/19/2015John H WeilandCOOSell8,413$174.99$1,472,190.87View SEC Filing  
2/19/2015John P GroetelaarsVPSell4,566$175.14$799,689.24View SEC Filing  
2/17/2015Jim C BeasleyInsiderSell9,904$174.58$1,729,040.32View SEC Filing  
2/17/2015John A DefordVPSell6,146$174.58$1,072,968.68View SEC Filing  
2/17/2015John H WeilandCOOSell13,616$174.51$2,376,128.16View SEC Filing  
2/17/2015Timothy M RingCEOSell6,284$174.75$1,098,129.00View SEC Filing  
2/12/2015Patricia G ChristianVPSell1,408$173.97$244,949.76View SEC Filing  
2/12/2015Timothy M RingCEOSell14,363$173.74$2,495,427.62View SEC Filing  
2/12/2015Timothy P CollinsInsiderSell6,564$174.00$1,142,136.00View SEC Filing  
2/9/2015Anthony WeltersDirectorSell1,563$169.02$264,178.26View SEC Filing  
1/22/2015Timothy M RingCEOSell20,000$177.84$3,556,800.00View SEC Filing  
12/22/2014Timothy M RingCEOSell32,325$169.64$5,483,613.00View SEC Filing  
12/17/2014Jim C BeasleyInsiderSell4,525$168.42$762,100.50View SEC Filing  
12/17/2014Sharon M LuboffVPSell3,564$168.36$600,035.04View SEC Filing  
12/16/2014Jim C BeasleyInsiderSell14,634$167.47$2,450,755.98View SEC Filing  
12/16/2014John A DefordVPSell5,626$167.47$942,186.22View SEC Filing  
12/16/2014John H WeilandCOOSell23,093$166.74$3,850,526.82View SEC Filing  
12/16/2014Timothy M RingCEOSell15,232$166.60$2,537,651.20View SEC Filing  
12/15/2014John H WeilandCOOSell13,589$166.56$2,263,383.84View SEC Filing  
12/10/2014Patricia G ChristianVPSell1,269$169.20$214,714.80View SEC Filing  
12/9/2014John H WeilandCOOSell6,350$170.32$1,081,532.00View SEC Filing  
12/9/2014Timothy M RingCEOSell9,550$170.20$1,625,410.00View SEC Filing  
10/27/2014Sharon M LuboffVPSell10,000$158.80$1,588,000.00View SEC Filing  
10/22/2014Timothy M RingCEOSell60,000$149.07$8,944,200.00View SEC Filing  
10/6/2014Timothy M RingCEOSell60,000$148.00$8,880,000.00View SEC Filing  
9/10/2014John H WeilandCOOSell27,179$149.50$4,063,260.50View SEC Filing  
9/2/2014Timothy M RingCEOSell10,228$148.83$1,522,233.24View SEC Filing  
8/4/2014Bronwen K KellyVPSell10,055$150.25$1,510,763.75View SEC Filing  
8/1/2014Timothy M RingCEOSell10,231$149.04$1,524,828.24View SEC Filing  
7/30/2014Timothy P CollinsInsiderSell30,914$150.38$4,648,847.32View SEC Filing  
7/29/2014Sharon M LuboffVPSell5,115$151.37$774,257.55View SEC Filing  
7/1/2014Timothy M RingCEOSell10,231$144.30$1,476,333.30View SEC Filing  
6/2/2014Timothy M RingCEOSell10,231$147.50$1,509,072.50View SEC Filing  
3/3/2014Timothy RingCEOSell10,231$142.23$1,455,155.13View SEC Filing  
2/27/2014Sharon LuboffVPSell9,914$144.86$1,436,142.04View SEC Filing  
2/20/2014Frank Lupisella, Jr.VPSell2,520$140.26$353,455.20View SEC Filing  
2/18/2014Marc BreslawskyDirectorSell2,400$141.34$339,216.00View SEC Filing  
2/11/2014John WeilandCOOSell9,328$135.32$1,262,264.96View SEC Filing  
2/11/2014Sharon LuboffVPSell1,400$135.00$189,000.00View SEC Filing  
1/16/2014John WeilandCOOSell81,500$136.13$11,094,595.00View SEC Filing  
1/13/2014Sharon LuboffVPSell2,500$135.00$337,500.00View SEC Filing  
12/12/2013Jim BeasleyInsiderSell9,802$133.98$1,313,271.96View SEC Filing  
12/12/2013John DefordVPSell2,792$133.98$374,072.16View SEC Filing  
12/10/2013John WeilandCOOSell10,389$137.30$1,426,409.70View SEC Filing  
12/10/2013Timothy RingCEOSell15,623$137.12$2,142,225.76View SEC Filing  
12/2/2013Timothy RingCEOSell10,231$138.85$1,420,574.35View SEC Filing  
11/6/2013David BarrettDirectorSell1,600$138.13$221,008.00View SEC Filing  
10/28/2013Herbert L HenkelDirectorSell2,400$134.66$323,184.00View SEC Filing  
10/28/2013Sharon M AlterioVPSell14,002$134.91$1,889,009.82View SEC Filing  
10/23/2013John H WeilandCOOSell60,210$134.01$8,068,742.10View SEC Filing  
10/21/2013John H WeilandCOOSell84,525$125.62$10,618,030.50View SEC Filing  
10/21/2013Timothy M RingCEOSell8,313$125.52$1,043,447.76View SEC Filing  
10/18/2013Gary D DolchVPSell10,000$125.00$1,250,000.00View SEC Filing  
9/24/2013Timothy RingCEOSell8,313$117.77$979,022.01View SEC Filing  
9/9/2013John A DefordVPSell28,364$117.89$3,343,831.96View SEC Filing  
9/3/2013Timothy RingCEOSell10,231$114.65$1,172,984.15View SEC Filing  
8/30/2013Jim BeasleyInsiderSell1,420$115.33$163,768.60View SEC Filing  
8/21/2013Timothy RingCEOSell8,313$113.24$941,364.12View SEC Filing  
8/12/2013Sharon AlterioVPSell13,379$117.01$1,565,476.79View SEC Filing  
8/5/2013Brian P KellyVPSell28,000$115.69$3,239,320.00View SEC Filing  
8/2/2013David M BarrettDirectorSell1,200$115.70$138,840.00View SEC Filing  
8/2/2013Frank Lupisella JrVPSell10,500$115.61$1,213,905.00View SEC Filing  
8/1/2013John H WeilandCOOSell87,336$115.35$10,074,207.60View SEC Filing  
7/29/2013Timothy P CollinsInsiderSell22,025$113.60$2,502,040.00View SEC Filing  
7/26/2013Anthony WeltersDirectorSell5,600$113.12$633,472.00View SEC Filing  
7/26/2013Jean F HollowayVPSell2,275$113.52$258,258.00View SEC Filing  
7/22/2013Timothy M RingCEOSell8,312$113.58$944,076.96View SEC Filing  
6/21/2013Timothy M RingCEOSell8,312$110.05$914,735.60View SEC Filing  
6/20/2013Gary D DolchVPSell14,569$109.97$1,602,152.93View SEC Filing  
5/21/2013Timothy M RingCEOSell8,312$106.65$886,474.80View SEC Filing  
5/20/2013Marc C BreslawskyDirectorSell2,400$107.20$257,280.00View SEC Filing  
5/8/2013Timothy M RingCEOSell8,312$102.00$847,824.00View SEC Filing  
4/11/2013G Mason MorfitInsiderSell300,000$102.47$30,741,000.00View SEC Filing  
4/9/2013Timothy M RingCEOSell8,312$102.00$847,824.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for C.R. Bard (NYSE:BCR)
DateHeadline
gurufocus.com logoSep 27, 2016 - C.r. Bard Inc (BCR) Chairman and CEO Timothy M ... - GuruFocus.com (NYSE:BCR)
www.gurufocus.com - September 28 at 3:52 PM
finance.yahoo.com logoC.r. Bard Inc (BCR) Chairman and CEO Timothy M Ring Sold $25.2 million of Shares (NYSE:BCR)
finance.yahoo.com - September 28 at 8:36 AM
News IconIs CR Bard Inc.(NYSE: BCR), a large market cap stock a smart buy ... - The Daily Leicester (NYSE:BCR)
thedailyleicester.com - September 27 at 3:46 PM
realistinvestor.com logoCR Bard, Inc. (NYSE:BCR): Price Target Stands At $240.6 - RealistInvestor.com (NYSE:BCR)
www.realistinvestor.com - September 27 at 3:46 PM
News IconInstitutional Move From SEC: Findlay Park Partners Llp Has Trimmed Bard C R INC (BCR) Stake as Market Value Rose - Chester News (NYSE:BCR)
www.chesterindependent.com - September 27 at 3:46 PM
stocksdaily.net logoCR Bard, Inc. (NYSE:BCR) Had $1030.9 In Cash And Short-Term Investments - Stocks Daily (NYSE:BCR)
www.stocksdaily.net - September 24 at 3:40 PM
finance.yahoo.com logoLUTONIX® Global Real-World Registry 24-Month Outcomes Presented at VIVA 2016 (NYSE:BCR)
finance.yahoo.com - September 22 at 9:38 AM
fidaily.com logoC.R. Bard, Inc. Common Stock (NYSE:BCR) Trading Up - Insider Trading Activity - Finance Daily (NYSE:BCR)
www.fidaily.com - September 20 at 5:55 PM
streetinsider.com logoC.R. Bard Inc. (BCR) Says FDA Approves 6-Month Primary End Point for Lutonix Below-the-Knee Drug Coated Balloon - StreetInsider.com (NYSE:BCR)
www.streetinsider.com - September 20 at 5:55 PM
capitalcube.com logoC.R. Bard, Inc. (New Jersey) – Value Analysis (NYSE:BCR) : September 20, 2016 (NYSE:BCR)
www.capitalcube.com - September 20 at 5:55 PM
4-traders.com logoC R Bard : FDA Approves 6-Month Primary End Point for the Lutonix® Below-the-Knee Drug Coated Balloon (NYSE:BCR)
www.4-traders.com - September 20 at 9:44 AM
nasdaq.com logoFDA Oks Primary End Point For Lutonix Below-the-Knee Drug Coated Balloon (NYSE:BCR)
www.nasdaq.com - September 20 at 9:44 AM
streetinsider.com logoC.R. Bard Inc. (BCR) Says FDA Approves 6-Month Primary End Point for Lutonix Below-the-Knee Drug Coated Balloon (NYSE:BCR)
www.streetinsider.com - September 20 at 9:44 AM
finance.yahoo.com logoFDA Approves 6-Month Primary End Point for the Lutonix® Below-the-Knee Drug Coated Balloon (NYSE:BCR)
finance.yahoo.com - September 20 at 9:44 AM
finance.yahoo.com logo5:39 pm C.R. Bard: FDA approves 6-month primary end point for the Lutonix below-the-knee drug coated balloon (NYSE:BCR)
finance.yahoo.com - September 20 at 9:44 AM
finance.yahoo.com logoCR Bard (BCR) Gets FDA's IDE Approval for Lutonix DCB (NYSE:BCR)
finance.yahoo.com - September 20 at 9:44 AM
capitalcube.com logoC.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bullish Manner : BCR-US : September 19, 2016 (NYSE:BCR)
www.capitalcube.com - September 19 at 8:32 AM
investornewswire.com logoExpected For C.R. Bard, Inc. (NYSE:BCR) Sales Of $4279.296 - Investor Newswire (NYSE:BCR)
www.investornewswire.com - September 18 at 3:42 PM
finance.yahoo.com logoC.R. Bard upgraded by Wells Fargo (NYSE:BCR)
finance.yahoo.com - September 16 at 3:45 PM
News IconC.R. Bard Inc. (NYSE: BCR) Stock Coverage Initiated at Evercore ISI - The Ledger Gazette (NYSE:BCR)
ledgergazette.com - September 16 at 8:18 AM
realistinvestor.com logoResearch Analysts Set C.R. Bard, Inc. (NYSE:BCR)'s Price Target At ... - RealistInvestor.com (NYSE:BCR)
www.realistinvestor.com - September 14 at 6:17 AM
News IconStock Valuation Recap for CR Bard Inc. (NYSE:BCR) - Post News (NYSE:BCR)
www.kentuckypostnews.com - September 10 at 3:41 PM
News IconThursday Trading Session Review: CR Bard Inc. (NYSE:BCR) - National Daily Press (NYSE:BCR)
www.nationaldailypress.com - September 10 at 3:41 PM
capitalcube.com logoETF’s with exposure to C.R. Bard, Inc. (New Jersey) : September 9, 2016 (NYSE:BCR)
www.capitalcube.com - September 9 at 3:43 PM
News IconInstitutional Investors Have Decreased Positions in CR Bard Inc. (NYSE:BCR) - Post News (NYSE:BCR)
www.kentuckypostnews.com - September 9 at 8:38 AM
News IconPlacing C.R. Bard, Inc. (NYSE:BCR) Shares Under the Microscope - Post News (NYSE:BCR)
www.kentuckypostnews.com - September 9 at 8:38 AM
News IconC.R. Bard, Inc. (NYSE:BCR) From The Analysts Point of View - National Daily Press (NYSE:BCR)
www.nationaldailypress.com - September 9 at 8:38 AM
News IconShares Higher Over the Last Five Trading Sessions: CR Bard Inc. (NYSE:BCR) - Post News (NYSE:BCR)
www.kentuckypostnews.com - September 6 at 8:53 PM
finance.yahoo.com logoBard to Present at Morgan Stanley Global Healthcare Conference (NYSE:BCR)
finance.yahoo.com - September 6 at 3:50 PM
investornewswire.com logoCan C.R. Bard, Inc. (NYSE:BCR) Surprise Analysts? - Investor Newswire (NYSE:BCR)
www.investornewswire.com - September 5 at 3:43 PM
investornewswire.com logoCan C.R. Bard, Inc. (NYSE:BCR) Surprise Analysts? - Investor Newswire (NYSE:BCR)
www.investornewswire.com - September 5 at 3:43 PM
News IconCR Bard Inc. (NYSE:BCR) – Top Stock from Healthcare Sector - The Daily Leicester (NYSE:BCR)
thedailyleicester.com - September 5 at 3:43 PM
News IconCR Bard Inc. (NYSE:BCR) – Top Stock from Healthcare Sector - The Daily Leicester (NYSE:BCR)
thedailyleicester.com - September 5 at 3:43 PM
News IconShares Posting Gains Over the Past Half Year: CR Bard Inc. (NYSE:BCR) - Post News (NYSE:BCR)
www.kentuckypostnews.com - September 5 at 8:35 AM
News IconStock Struggling for the Quarter: CR Bard Inc. (NYSE:BCR) - Post News (NYSE:BCR)
www.kentuckypostnews.com - September 4 at 3:39 PM
News IconTop Gainers of the Day: CR Bard Inc. (NYSE:BCR) from Medical ... - Twin County News (NYSE:BCR)
twincountynews.com - September 2 at 4:31 PM
News IconInstitutions Have Decreased Positions in CR Bard Inc. (NYSE:BCR) - Post News (NYSE:BCR)
www.kentuckypostnews.com - September 2 at 8:30 AM
News IconIs CR Bard Inc. (NYSE:BCR), a large market cap stock a smart buy? - Twin County News (NYSE:BCR)
twincountynews.com - September 1 at 3:46 PM
marketrealist.com logoA Look at How C.R. Bard’s Valuation Compares to Its Peers (NYSE:BCR)
marketrealist.com - September 1 at 12:14 PM
marketrealist.com logoAnalysts’ Recommendations for C.R. Bard in 2016 (NYSE:BCR)
marketrealist.com - August 31 at 3:46 PM
marketrealist.com logoAnalysts’ Recommendations for C.R. Bard in 2016 (NYSE:BCR)
marketrealist.com - August 31 at 3:46 PM
marketrealist.com logoC.R. Bard Is Expected to Have a Strong Performance in 2016 (NYSE:BCR)
marketrealist.com - August 31 at 3:46 PM
marketrealist.com logoC.R. Bard Is Expected to Have a Strong Performance in 2016 (NYSE:BCR)
marketrealist.com - August 31 at 3:46 PM
News IconTop Gainers of the Day: CR Bard Inc. (NYSE:BCR) from Medical Instruments & Supplies - Twin County News (NYSE:BCR)
twincountynews.com - August 31 at 8:35 AM
News IconStock Up Over the Past Five Trading Days: CR Bard Inc. (NYSE:BCR) - Post News (NYSE:BCR)
www.kentuckypostnews.com - August 30 at 9:10 AM
capitalcube.com logoETF’s with exposure to C.R. Bard, Inc. (New Jersey) : August 29, 2016 (NYSE:BCR)
www.capitalcube.com - August 29 at 4:21 PM
stocksdaily.net logoCR Bard, Inc. (NYSE:BCR) Paying Out $-69.4 Million In Dividends - Stocks Daily (NYSE:BCR)
www.stocksdaily.net - August 28 at 8:32 AM
News IconIs this Large Market Cap Stock target price reasonable for CR Bard Inc. (NYSE:BCR)? - The Daily Leicester (NYSE:BCR)
thedailyleicester.com - August 19 at 4:26 PM
capitalcube.com logoETF’s with exposure to C.R. Bard, Inc. (New Jersey) : August 18, 2016 (NYSE:BCR)
www.capitalcube.com - August 18 at 9:14 PM
News IconShares Moving Lower Over the Past Month CR Bard Inc. (NYSE:BCR) - Post News (NYSE:BCR)
www.kentuckypostnews.com - August 18 at 12:11 PM

Social

C.R. Bard (NYSE:BCR) Chart for Thursday, September, 29, 2016


Last Updated on 9/29/2016 by MarketBeat.com Staff